Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Smoking, diabetes and hyperlipidaemia.

D P Mikhailidis1, J A Papadakis, E S Ganotakis

  • 1Department of Chemical Pathology & Human Metabolism, Royal Free Hospital & School of Medicine, Univ. of London, United Kingdom.

Journal of the Royal Society of Health
|March 17, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Endocrine Disorders and Peripheral Arterial Disease - A Series of Reviews Cushing Syndrome-Cortisol Excess.

Current vascular pharmacology·2023
Same author

Growth Hormone, Atherosclerosis and Peripheral Arterial Disease: Exploring the Spectrum from Acromegaly to Growth Hormone Deficiency.

Current vascular pharmacology·2023
Same author

Nonalcoholic Fatty Pancreas Disease: Role in Metabolic Syndrome, "Prediabetes," Diabetes and Atherosclerosis.

Digestive diseases and sciences·2021
Same author

Multifocal arterial disease: clinical implications and management.

Current opinion in cardiology·2020
Same author

Preface.

Current vascular pharmacology·2018
Same author

Daylight saving time and myocardial infarction: should we be worried? A review of the evidence.

European review for medical and pharmacological sciences·2018
Same journal

Re: Sexually transmitted diseases among women in Coventry.

Journal of the Royal Society of Health·1999
Same journal

Re: Essential oils and 'aromatherapy' their modern role in healing.

Journal of the Royal Society of Health·1999
Same journal

Historical perspectives on health. A historical approach to study of the function and dysfunction of the thyroid gland realised?

Journal of the Royal Society of Health·1999
Same journal

The growing influence of non governmental organisations (NGOs) in international health: challenges and opportunities.

Journal of the Royal Society of Health·1999
Same journal

Lessons to be learned: a case study approach. Primary hyperparathyroidism simulating an acute severe polyneuritis.

Journal of the Royal Society of Health·1999
Same journal

Some peoples' psychological experiences of attending a sexual health clinic and having a sexually transmitted infection.

Journal of the Royal Society of Health·1999
See all related articles

Smoking significantly increases the risk of developing insulin resistance and non-insulin dependent diabetes (NIDDM). Quitting smoking reduces this risk and improves lipid profiles, highlighting its importance for diabetes prevention and management.

Area of Science:

  • Endocrinology
  • Public Health
  • Cardiovascular Medicine

Background:

  • Epidemiological studies show a strong link between smoking and insulin resistance.
  • A dose-response relationship exists between smoking and the risk of non-insulin dependent diabetes (NIDDM).
  • Impaired glucose tolerance (IGT) may precede NIDDM, and smoking is biochemically linked to both.

Purpose of the Study:

  • To review the epidemiological and biochemical evidence linking smoking to insulin resistance and NIDDM.
  • To highlight the impact of smoking on diabetic complications and cardiovascular risk.
  • To emphasize the benefits of smoking cessation on metabolic and lipid profiles.

Main Methods:

  • Review of epidemiological data on smoking, insulin resistance, and NIDDM.

Related Experiment Videos

  • Analysis of biochemical mechanisms underlying the smoking-IGT/NIDDM relationship.
  • Examination of the effects of smoking cessation on cardiovascular risk factors.

    • Main Results:

    • Smoking is a significant risk factor for insulin resistance, NIDDM, and its complications (nephropathy, neuropathy, retinopathy).
    • Smokers exhibit both insulin resistance and lipid intolerance.
    • Smoking cessation improves HDL and reduces LDL levels, even with potential weight gain.

    Conclusions:

    • Smoking cessation positively impacts cardiovascular risk factors and reduces the likelihood of developing NIDDM.
    • Healthcare providers should address smoking as a modifiable risk factor for diabetes and cardiovascular events.
    • Public health initiatives should emphasize smoking's role in diabetes development and progression.